Betashares Global Healthcare ETF - Currency Hedged
What DRUG does
The Betashares Global Healthcare ETF - Currency Hedged (ticker: DRUG) allows investors to gain exposure to a diverse range of global healthcare companies. This ETF invests in a broad selection of healthcare firms, including those involved in pharmaceuticals, biotechnology, and medical equipment, providing a way to benefit from the growth and innovation in the healthcare sector worldwide. The currency hedging feature helps protect Australian investors from fluctuations in foreign exchange rates, ensuring that returns are more closely aligned with the actual performance of the underlying investments. With a management fee of 0.57%, this ETF offers a straightforward way to invest in the global healthcare industry while managing currency risk.
Management Fee
0.57%
Distribution Yield
0.31%
Fund Under Management
$172M
+10.16M
Monthly Liquidity
7.61%
Spread
0.20%
Last Price
...
Product Type
ETFMonthly fund flows
Monthly Flow
$-3.53M
12-Month Flow
$-29.71M
Trading Activity
Transacted Value
$13M
Volume
1,540,371
Number of Trades
1,663
Monthly Liquidity
7.61%
Performance
1 Month
8.47%
1 Year
5.87%
3 Year
5.16%
5 Year
7.32%
Total Return
Share Price Chart
Related ETFs
Betashares 2028 Fixed Term Corporate Bond Active ETF
Betashares 2029 Fixed Term Corporate Bond Active ETF
Betashares 2030 Fixed Term Corporate Bond Active ETF
Betashares Australia 200 ETF
n/a
Betashares Australian High Interest Cash ETF
Betashares Ethical Australian Bond ETF
Resources
Should you buy Betashares Global Healthcare ETF - Currency Hedged right now?
While DRUG looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now